19AQMM26F1521 - Sole Source Justification Under Federal Supply Schedule: 20262027 Flu vaccines

Awarded Limited / Sole Source Justification Posted

Solicitation number
19AQMM26F1521
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
19AQMM26F1521 Federal contract award
Place of performance
Durham, North Carolina, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of State Office of Acquisition Management has awarded a sole-source delivery order to Glaxosmith Kline under the Department of Veterans Affairs federal supply schedule (contract 36F79722D0178) for Fluarix and Flulaval Influenza vaccines, with an estimated order value of $686,968.00.

The justification cites FAR 8.405-6(a)(1)(i)(B), establishing that Glaxosmith Kline is the only source capable of providing these supplies at the required quality level. The vaccines are proprietary products unique to Glaxosmith Kline—the sole manufacturer of both Fluarix and Flulaval pediatric and adult influenza vaccines, which are the first Trivalent pediatric and adult flu vaccines approved by the FDA. The delivery order is structured as Firm-Fixed-Price with no planned competitive solicitation.

The vaccines are required to immunize embassy personnel and pediatric family members at over 200 embassies and consulates as disease prevention against four influenza virus strains for the 2026-2027 flu season. Supplies include Fluarix and Flulaval in prefilled syringes (10 per box). Cold chain storage will be maintained at an approved government receiving point, with the Office of Global Operations coordinating timely distribution to embassies and consulates before the start of the 2026-2027 flu season. The contracting officer has determined the anticipated contract action represents best value and will evaluate the resultant price for reasonableness before award.

Notice text

Annual delivery order issued on a sole-source basis from the Department of Veteran’s Affairs Glaxosmith Kline federal supply schedule for pharmaceuticals and vaccines. The specific contract number is 36F79722D0178. The delivery order will be for proprietary Fluarix and Flulaval Influenza vaccines. 

Awarded contract 19AQMM26F1521 to unknown vendor for unknown amount on 2026-09-18.

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors